Concepts (88)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthroplasty, Replacement, Hip | 6 | 2019 | 48 | 2.120 |
Why?
|
| Arthroplasty, Replacement, Knee | 4 | 2022 | 84 | 2.110 |
Why?
|
| Humanities | 2 | 2022 | 2 | 1.750 |
Why?
|
| Curriculum | 2 | 2022 | 196 | 1.510 |
Why?
|
| Hip Prosthesis | 5 | 2019 | 12 | 1.240 |
Why?
|
| Femur | 4 | 2022 | 67 | 1.060 |
Why?
|
| Gastroparesis | 1 | 2023 | 10 | 0.940 |
Why?
|
| Orthopedics | 2 | 2021 | 93 | 0.850 |
Why?
|
| Fractures, Stress | 1 | 2022 | 11 | 0.820 |
Why?
|
| Arthritis | 1 | 2022 | 37 | 0.810 |
Why?
|
| Intraoperative Care | 2 | 2019 | 48 | 0.800 |
Why?
|
| Tibial Fractures | 1 | 2022 | 40 | 0.800 |
Why?
|
| Postoperative Complications | 2 | 2019 | 670 | 0.780 |
Why?
|
| Noise, Occupational | 1 | 2020 | 2 | 0.740 |
Why?
|
| Hearing Loss, Noise-Induced | 1 | 2020 | 3 | 0.740 |
Why?
|
| Povidone-Iodine | 1 | 2019 | 2 | 0.720 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2019 | 13 | 0.720 |
Why?
|
| Pubic Symphysis | 1 | 2018 | 4 | 0.670 |
Why?
|
| Sacroiliac Joint | 1 | 2018 | 13 | 0.660 |
Why?
|
| Pelvic Bones | 1 | 2018 | 31 | 0.650 |
Why?
|
| Histology | 1 | 2017 | 5 | 0.630 |
Why?
|
| Costs and Cost Analysis | 1 | 2017 | 88 | 0.610 |
Why?
|
| Health Care Costs | 1 | 2017 | 108 | 0.570 |
Why?
|
| Knee Joint | 1 | 2017 | 129 | 0.570 |
Why?
|
| Pain, Postoperative | 1 | 2018 | 174 | 0.560 |
Why?
|
| Humans | 18 | 2023 | 29123 | 0.480 |
Why?
|
| Hip Joint | 2 | 2014 | 57 | 0.430 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2011 | 56 | 0.420 |
Why?
|
| Femur Neck | 1 | 2011 | 19 | 0.400 |
Why?
|
| Femur Head | 1 | 2011 | 12 | 0.400 |
Why?
|
| Ossification, Heterotopic | 1 | 2011 | 14 | 0.400 |
Why?
|
| Joint Diseases | 1 | 2009 | 33 | 0.330 |
Why?
|
| Tendinopathy | 1 | 2007 | 10 | 0.310 |
Why?
|
| Tendons | 1 | 2007 | 57 | 0.310 |
Why?
|
| Retrospective Studies | 6 | 2017 | 3112 | 0.310 |
Why?
|
| Hand | 1 | 2007 | 63 | 0.300 |
Why?
|
| Calcinosis | 1 | 2007 | 143 | 0.290 |
Why?
|
| Clinical Competence | 1 | 2009 | 307 | 0.280 |
Why?
|
| Adult | 5 | 2020 | 8426 | 0.250 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2023 | 11 | 0.240 |
Why?
|
| Fasting | 1 | 2023 | 93 | 0.230 |
Why?
|
| Muscle, Skeletal | 1 | 2007 | 494 | 0.230 |
Why?
|
| Young Adult | 4 | 2017 | 2402 | 0.230 |
Why?
|
| Prosthesis-Related Infections | 2 | 2016 | 23 | 0.220 |
Why?
|
| Tibia | 1 | 2022 | 56 | 0.200 |
Why?
|
| Aged | 4 | 2018 | 9492 | 0.200 |
Why?
|
| Gloves, Surgical | 1 | 2021 | 3 | 0.200 |
Why?
|
| Protective Clothing | 1 | 2021 | 26 | 0.190 |
Why?
|
| Female | 7 | 2018 | 18173 | 0.190 |
Why?
|
| North Carolina | 2 | 2022 | 1423 | 0.190 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 3719 | 0.180 |
Why?
|
| Male | 6 | 2018 | 17815 | 0.180 |
Why?
|
| Arthroplasty | 1 | 2019 | 29 | 0.180 |
Why?
|
| Radiography | 2 | 2011 | 353 | 0.160 |
Why?
|
| Rotation | 1 | 2018 | 46 | 0.160 |
Why?
|
| Cadaver | 1 | 2018 | 143 | 0.160 |
Why?
|
| Osteoarthritis | 1 | 2017 | 74 | 0.150 |
Why?
|
| Pilot Projects | 1 | 2018 | 469 | 0.150 |
Why?
|
| Middle Aged | 3 | 2017 | 10834 | 0.130 |
Why?
|
| Osteoarthritis, Hip | 1 | 2014 | 15 | 0.120 |
Why?
|
| Radiographic Image Enhancement | 1 | 2014 | 30 | 0.120 |
Why?
|
| Orthopedic Procedures | 1 | 2014 | 92 | 0.110 |
Why?
|
| Incidence | 2 | 2016 | 1119 | 0.110 |
Why?
|
| Treatment Outcome | 3 | 2009 | 3101 | 0.110 |
Why?
|
| Prosthesis Design | 1 | 2009 | 87 | 0.080 |
Why?
|
| Arthroscopy | 1 | 2011 | 199 | 0.080 |
Why?
|
| Risk Factors | 2 | 2016 | 3537 | 0.080 |
Why?
|
| Splints | 1 | 2007 | 13 | 0.080 |
Why?
|
| Polymethyl Methacrylate | 1 | 2007 | 11 | 0.080 |
Why?
|
| Bone Cements | 1 | 2007 | 10 | 0.080 |
Why?
|
| Knee Prosthesis | 1 | 2007 | 14 | 0.080 |
Why?
|
| Anesthetics, Local | 1 | 2007 | 77 | 0.070 |
Why?
|
| Case-Control Studies | 1 | 2009 | 859 | 0.070 |
Why?
|
| Glucocorticoids | 1 | 2007 | 149 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2011 | 871 | 0.070 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 2109 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2007 | 285 | 0.060 |
Why?
|
| Time Factors | 1 | 2009 | 2001 | 0.060 |
Why?
|
| United States | 1 | 2011 | 3632 | 0.060 |
Why?
|
| Cross-Over Studies | 1 | 2021 | 94 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2014 | 726 | 0.050 |
Why?
|
| Osteotomy | 1 | 2019 | 49 | 0.040 |
Why?
|
| Arthritis, Infectious | 1 | 2016 | 21 | 0.040 |
Why?
|
| Clinical Protocols | 1 | 2016 | 95 | 0.040 |
Why?
|
| Patient Readmission | 1 | 2016 | 105 | 0.030 |
Why?
|
| Preoperative Care | 1 | 2014 | 110 | 0.030 |
Why?
|
| Equipment Design | 1 | 2007 | 167 | 0.020 |
Why?
|
| Adolescent | 1 | 2011 | 3255 | 0.010 |
Why?
|